Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion +10,443 10,443
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion +4,747 15,190
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion +24,089 39,279
2015-10-06 Einhorn Andrew J. Chief Financial Officer Other acquisition +2,377 $6.79 $16K 41,656
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion +15,720 15,720
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion +21,221 36,941
2015-10-06 Einhorn Andrew J. Chief Financial Officer Purchase +45,000 $11.00 $495K 81,941
2015-10-06 Einhorn Andrew J. Chief Financial Officer Other acquisition +1,651 $7.75 $13K 83,592
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion · Series B-1 Convertible Preferred Stock −14,286 0
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion · Series C Convertible Preferred Stock −6,494 0
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion · Series C-1 Convertible Preferred Stock −32,956 0
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion · Series C-1 Convertible Preferred Stock −21,506 0
2015-10-06 Einhorn Andrew J. Chief Financial Officer Conversion · Series C-2 Convertible Preferred Stock −29,032 0
2015-10-06 Hove Anders D Director Conversion +1,571,917 1,571,917
2015-10-06 Hove Anders D Director Purchase +450,000 $11.00 $5.0M 2,021,917
2015-10-06 Hove Anders D Director Other acquisition +46,665 $8.60 $401K 2,068,582
2015-10-06 Hove Anders D Director Conversion · Series C-2 Convertible Preferred Stock −2,150,538 0
2015-10-06 Leuthner Brian A Chief Executive Officer Conversion +2,672 550,878
2015-10-06 Leuthner Brian A Chief Executive Officer Other acquisition +80 $8.60 $688 550,958
2015-10-06 Leuthner Brian A Chief Executive Officer Conversion · Series C-2 Convertible Preferred Stock −3,655 0

Page 17 of 18 · 346 trades